Proteomics of immune cells from liver tumors reveals immunotherapy targets
Canale et al. employed mass spectrometry-based proteomics to analyze immune cells from blood, liver, and tumor tissues of 48 hepatocellular carcinoma patients. They identified significant phenotype...
cell.com